G
Guardant Health
Conquering Cancer with Blood Tests
Redwood City, CA
2,500+
About Guardant Health
Industry:
Diagnostics
Founded:
2012
Founders:
Helmy Eltoukhy, AmirAli Talasaz
Status:
Public (NASDAQ: GH)
Funding & Growth
Total Raised:
$800M+
Valuation:
$5B+ market cap
Stage:
Public
Key Investors:
Sequoia
Khosla Ventures
OrbiMed
✓ Pros
- • Leader in liquid biopsy
- • Strong growth trajectory
- • Bay Area location
- • Meaningful cancer detection work
- • Good equity potential
✗ Cons
- • Competitive diagnostics market
- • Reimbursement challenges
- • Fast-paced environment
- • Path to profitability